1. 26. A randomized controlled cross-over double blind study protocol on THC/CBD oromucosal spray as an add-on therapy for post-stroke spasticity. Issue 12 (December 2017) Authors: Marinelli, L.; Balestrino, M.; Mori, L.; Puce, L.; Rosa, G.; Giorello, L.; Currà, A.; Fattapposta, F.; Serrati, C.; Gandolfo, C.; Abbruzzese, G.; Trompetto, C. Journal: Clinical neurophysiology Issue: Volume 128:Issue 12(2017:Dec.) Page Start: e421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine. (September 2015) Authors: Queirolo, P.; Spagnolo, F.; Picasso, V.; Simeone, E.; Grimaldi, A.M.; Curvietto, M.; Giorello, L.; Fontana, V.; Merlo, D.F.; Ascierto, P.A.; Bruzzi, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗